Your browser doesn't support javascript.
loading
Modelling the skeletal muscle injury recovery using in vivo contrast-enhanced micro-CT: a proof-of-concept study in a rat model.
Paun, Bruno; Leon, Daniel García; Cabello, Alex Claveria; Pages, Roso Mares; de la Calle Vargas, Elena; Muñoz, Paola Contreras; Garcia, Vanessa Venegas; Castell-Conesa, Joan; Baleriola, Mario Marotta; Camacho, Jose Raul Herance.
Afiliação
  • Paun B; Medical Molecular Imaging Group, Vall d'Hebron Research Institute (VHIR), CIBER-BBN, CIBBIM-Nanomedicine, ISCIII, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
  • Leon DG; Medical Molecular Imaging Group, Vall d'Hebron Research Institute (VHIR), CIBER-BBN, CIBBIM-Nanomedicine, ISCIII, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
  • Cabello AC; Medical Molecular Imaging Group, Vall d'Hebron Research Institute (VHIR), CIBER-BBN, CIBBIM-Nanomedicine, ISCIII, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
  • Pages RM; Medical Molecular Imaging Group, Vall d'Hebron Research Institute (VHIR), CIBER-BBN, CIBBIM-Nanomedicine, ISCIII, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
  • de la Calle Vargas E; Medical Molecular Imaging Group, Vall d'Hebron Research Institute (VHIR), CIBER-BBN, CIBBIM-Nanomedicine, ISCIII, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
  • Muñoz PC; Health & Biomedicine division, Leitat Technological Center, 2. C/ Pallars, 179-185, 08005, Barcelona, Spain.
  • Garcia VV; Bioengineering, Cell therapy and Surgery in Congenital Malformations Laboratory, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
  • Castell-Conesa J; Health & Biomedicine division, Leitat Technological Center, 2. C/ Pallars, 179-185, 08005, Barcelona, Spain.
  • Baleriola MM; Bioengineering, Cell therapy and Surgery in Congenital Malformations Laboratory, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
  • Camacho JRH; Medical Molecular Imaging Group, Vall d'Hebron Research Institute (VHIR), CIBER-BBN, CIBBIM-Nanomedicine, ISCIII, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Eur Radiol Exp ; 4(1): 33, 2020 06 03.
Article em En | MEDLINE | ID: mdl-32488324
BACKGROUND: Skeletal muscle injury characterisation during healing supports trauma prognosis. Given the potential interest of computed tomography (CT) in muscle diseases and lack of in vivo CT methodology to image skeletal muscle wound healing, we tracked skeletal muscle injury recovery using in vivo micro-CT in a rat model to obtain a predictive model. METHODS: Skeletal muscle injury was performed in 23 rats. Twenty animals were sorted into five groups to image lesion recovery at 2, 4, 7, 10, or 14 days after injury using contrast-enhanced micro-CT. Injury volumes were quantified using a semiautomatic image processing, and these values were used to build a prediction model. The remaining 3 rats were imaged at all monitoring time points as validation. Predictions were compared with Bland-Altman analysis. RESULTS: Optimal contrast agent dose was found to be 20 mL/kg injected at 400 µL/min. Injury volumes showed a decreasing tendency from day 0 (32.3 ± 12.0mm3, mean ± standard deviation) to day 2, 4, 7, 10, and 14 after injury (19.6 ± 12.6, 11.0 ± 6.7, 8.2 ± 7.7, 5.7 ± 3.9, and 4.5 ± 4.8 mm3, respectively). Groups with single monitoring time point did not yield significant differences with the validation group lesions. Further exponential model training with single follow-up data (R2 = 0.968) to predict injury recovery in the validation cohort gave a predictions root mean squared error of 6.8 ± 5.4 mm3. Further prediction analysis yielded a bias of 2.327. CONCLUSION: Contrast-enhanced CT allowed in vivo tracking of skeletal muscle injury recovery in rat.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cicatrização / Iopamidol / Músculo Esquelético / Meios de Contraste / Microtomografia por Raio-X Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cicatrização / Iopamidol / Músculo Esquelético / Meios de Contraste / Microtomografia por Raio-X Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article